Pages that link to "Q66680131"
Jump to navigation
Jump to search
The following pages link to Xiangguo Qiu (Q66680131):
Displaying 50 items.
- Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses (Q21562420) (← links)
- Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb (Q24863601) (← links)
- Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs (Q24604416) (← links)
- Spread of ZIKV and YFV to China: Potential Implications (Q24657479) (← links)
- More Challenges From Ebola: Infection of the Central Nervous System (Q28390883) (← links)
- Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice (Q30375073) (← links)
- Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus (Q33417197) (← links)
- Delivering Prolonged Intensive Care to a Non-human Primate: A High Fidelity Animal Model of Critical Illness (Q33682491) (← links)
- Deep-sequencing of Marburg virus genome during sequential mouse passaging and cell-culture adaptation reveals extensive changes over time (Q33794406) (← links)
- Post-exposure therapy of filovirus infections (Q34040813) (← links)
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp (Q34426585) (← links)
- Structures of protective antibodies reveal sites of vulnerability on Ebola virus (Q34661120) (← links)
- The multiple roles of sGP in Ebola pathogenesis (Q34869463) (← links)
- Ebola virus transmission in guinea pigs (Q34991054) (← links)
- Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection (Q35842390) (← links)
- Progression of Ebola Therapeutics During the 2014-2015 Outbreak (Q35895955) (← links)
- A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection (Q35917501) (← links)
- Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates (Q36043199) (← links)
- Ebola viral load at diagnosis associates with patient outcome and outbreak evolution (Q36335863) (← links)
- Development and Characterization of a Guinea Pig-Adapted Sudan Virus (Q36433906) (← links)
- Can Ebola virus become endemic in the human population? (Q36447887) (← links)
- Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection (Q36789989) (← links)
- Potent neutralizing monoclonal antibodies against Ebola virus infection (Q36903111) (← links)
- Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site (Q36913606) (← links)
- Antibody therapy for Ebola: is the tide turning around? (Q36977744) (← links)
- Antibody therapeutics for Ebola virus disease (Q36994087) (← links)
- Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection (Q37203877) (← links)
- Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates (Q37213207) (← links)
- Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease (Q37300391) (← links)
- The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies (Q37448307) (← links)
- Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. (Q37631492) (← links)
- Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination (Q37678872) (← links)
- Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus (Q37738447) (← links)
- Characterization of host immune responses in Ebola virus infections (Q38205274) (← links)
- Development of experimental and early investigational drugs for the treatment of Ebola virus infections (Q38524949) (← links)
- Clinical Evaluation of Ebola Virus Disease Therapeutics (Q38617605) (← links)
- Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus (Q38782718) (← links)
- An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates (Q38834286) (← links)
- The emergence of antibody therapies for Ebola (Q38912605) (← links)
- Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo (Q39138259) (← links)
- Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques (Q39601175) (← links)
- Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection (Q40054412) (← links)
- Characterization of Sudan Ebolavirus infection in ferrets (Q40055469) (← links)
- Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability. (Q40056179) (← links)
- Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses. (Q40056187) (← links)
- Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus (Q40061368) (← links)
- Ultrasensitive Ebola Virus Detection Based on Electroluminescent Nanospheres and Immunomagnetic Separation (Q40068609) (← links)
- Synergistic drug combination effectively blocks Ebola virus infection (Q40078596) (← links)
- Inactivation of Zaire ebolavirus Variant Makona in Human Serum Samples Analyzed by Enzyme-Linked Immunosorbent Assay (Q40091064) (← links)
- Designing Efficacious Vesicular Stomatitis Virus-Vectored Vaccines Against Ebola Virus (Q40109987) (← links)